- Home
- Publications
- Publication Search
- Publication Details
Title
Bias and inconsistency in the estimation of tumour mutation burden
Authors
Keywords
-
Journal
BMC CANCER
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-02
DOI
10.1186/s12885-022-09897-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
- (2021) Hana Štorkánová et al. Scientific Reports
- High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types
- (2021) D.J. McGrail et al. ANNALS OF ONCOLOGY
- FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors
- (2021) Leigh Marcus et al. CLINICAL CANCER RESEARCH
- TMB or not TMB as a biomarker: That is the question
- (2021) Alfredo Addeo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study
- (2021) Dorte Schou Nørøxe et al. Molecular Oncology
- Challenges in bioinformatics approaches to tumor mutation burden analysis
- (2021) Francesca Fenizia et al. Oncology Letters
- Efficacy of Immune Checkpoint Inhibitors in Rare Tumours: A Systematic Review
- (2021) Fausto Petrelli et al. Frontiers in Immunology
- Prognostic Role of Tumor Mutational Burden in Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
- (2021) Taobi Huang et al. Frontiers in Oncology
- Re-epithelialization and immune cell behaviour in an ex vivo human skin model
- (2020) Ana Rakita et al. Scientific Reports
- The positive correlation between tumor mutation burden and the purity of tumor samples in non–small cell lung cancer and colorectal cancer.
- (2020) Jian Tong et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of an Integrated Pan-Cancer Oncology Enrichment Next-Generation Sequencing Assay to Measure Tumour Mutational Burden and Detect Clinically Actionable Variants
- (2020) Valerie Pestinger et al. Molecular Diagnosis & Therapy
- Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence
- (2020) Raju K. Vaddepally et al. Cancers
- Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment
- (2020) Amblessed E. Onuma et al. GENE EXPRESSION
- Promising predictors of checkpoint inhibitor response in NSCLC
- (2020) Friedlaender Alex et al. Expert Review of Anticancer Therapy
- Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors
- (2020) Rilan Bai et al. Biomarker Research
- Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
- (2020) John H. Strickler et al. CLINICAL CANCER RESEARCH
- Tumor mutational burden (TMB) standardization initiatives: Recommendations for consistent TMB assessment in clinical samples to guide immunotherapy treatment decisions
- (2019) Albrecht Stenzinger et al. GENES CHROMOSOMES & CANCER
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Assessment of tumor mutation burden calculation from gene panel sequencing data
- (2019) Zhenwu Xu et al. OncoTargets and Therapy
- Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
- (2019) Laura Fancello et al. Journal for ImmunoTherapy of Cancer
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing
- (2018) Hira Rizvi et al. JOURNAL OF CLINICAL ONCOLOGY
- Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations
- (2018) Matteo Allegretti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- The role of neoantigens in response to immune checkpoint blockade
- (2016) Nadeem Riaz et al. INTERNATIONAL IMMUNOLOGY
- Somatic mutation detection using various targeted detection assays in paired samples of circulating tumor DNA, primary tumor and metastases from patients undergoing resection of colorectal liver metastases
- (2016) Nick Beije et al. Molecular Oncology
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
- (2016) D. B. Johnson et al. Cancer Immunology Research
- Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data
- (2016) Anne Bruun Krøigård et al. PLoS One
- Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
- (2015) Cyrille J. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive cancer-gene panels can be used to estimate mutational load and predict clinical benefit to PD-1 blockade in clinical practice
- (2015) Luís Felipe Campesato et al. Oncotarget
- Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data
- (2013) David H. Spencer et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data
- (2013) Yuichi Shiraishi et al. NUCLEIC ACIDS RESEARCH
- Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers
- (2013) Qingguo Wang et al. Genome Medicine
- Virmid: accurate detection of somatic mutations with sample impurity inference
- (2013) Sangwoo Kim et al. GENOME BIOLOGY
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
- (2012) Christopher T. Saunders et al. BIOINFORMATICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started